Food BioSciences Department, Teagasc Food Research Centre, Ashtown, Dublin 15, Ireland.
J Agric Food Chem. 2011 Jul 13;59(13):6829-36. doi: 10.1021/jf201114d. Epub 2011 Jun 6.
Macroalgae have for centuries been consumed whole among the East Asian populations of China, Korea, and Japan. Due to the environment in which they grow, macroalgae produce unique and interesting biologically active compounds. Protein can account for up to 47% of the dry weight of macroalgae depending on species and time of cultivation and harvest. Peptides derived from marcoalgae are proven to have hypotensive effects in the human circulatory system. Hypertension is one of the major, yet controllable, risk factors in cardiovascular disease (CVD). CVD is the main cause of death in Europe, accounting for over 4.3 million deaths each year. In the United States it affects one in three individuals. Hypotensive peptides derived from marine and other sources have already been incorporated into functional foods such as beverages and soups. The purpose of this review is to highlight the potential of heart health peptides from macroalgae and to discuss the feasibility of expanding the variety of foods these peptides may be used in.
海藻在几个世纪以来一直被东亚的中国、韩国和日本人群食用。由于其生长的环境,海藻产生独特而有趣的具有生物活性的化合物。海藻的蛋白质含量根据物种和培养及收获时间的不同,可占到干重的 47%。从海藻中提取的肽类已被证明对人体循环系统具有降血压的作用。高血压是心血管疾病(CVD)的主要但可控制的危险因素之一。CVD 是欧洲主要的死亡原因,每年导致超过 430 万人死亡。在美国,每三个人中就有一个人受到影响。从海洋和其他来源提取的降血压肽已被纳入功能性食品,如饮料和汤。本综述的目的是强调海藻来源的心脏健康肽的潜力,并讨论扩大这些肽可能应用于的食品种类的可行性。